SCHEMBL2698628

SCHEMBL2698628

CC(C)(O)C(C)(C)OB(O)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 1/20 0.45
TSHR P16473 3/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 4/20 0.41
ACHE P22303 1/20 0.41
ALOX15 P16050 1/20 0.41
PRSS1 P07477 3/20 0.40
PRSS2 P07478 3/20 0.40
PRSS3 P35030 3/20 0.40
F2 P00734 2/20 0.40
ALOX5 P09917 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1608761 0.82 ALDH1A1 (0.40) ALDH1A1ACHEGAACES1CA1
SCHEMBL6702103 0.80 MEN1 (0.43) PTPRCLMNAALDH1A1KMT2ASMN1; SMN2
SCHEMBL6500392 0.79 TSHR (0.52) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL557225 0.78 MEN1 (0.38) LMNAALOX5GAAHTTKMT2A
SCHEMBL77037 0.78 TSHR (0.44) TSHRLMNAALDH1A1ALOX15GAA
SCHEMBL2700555 0.77 TSHR (0.42) TSHRLMNAALDH1A1GAAKMT2A
SCHEMBL517851 0.76 ENPP2 (0.48) TSHRLMNAALDH1A1ACHECA2
SCHEMBL16223353 0.76 ACHE (0.35) LMNAALDH1A1ACHEKMT2A
SCHEMBL28022638 0.76 TSHR (0.52) TSHRLMNAALDH1A1ACHEALOX15
SCHEMBL27995557 0.76 TSHR (0.52) TSHRLMNAALDH1A1ACHEALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8569331-B2 Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds ARQULE, INC. (US) 2013-10-29 US disclosed
WO-2012061342-A2 SUBSTITUTED BENZO-IMIDAZO-PYRIDO-DIAZEPINE COMPOUNDS ARQULE, INC. (US) 2012-05-10 WO disclosed
US-20120108574-A1 Substituted Benzo-Imidazo-Pyrido-Diazepine Compounds ARQULE, INC. (US) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108574-A1 Substituted Benzo-Imidazo-Pyrido-Diazepine Compounds BRD4, BRPF3, BRD3 PTPRC 1222/4885TSHR 2768/4885LMNA 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.